Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Bioengineered ; 13(3): 6558-6566, 2022 03.
Artigo em Inglês | MEDLINE | ID: mdl-35220882

RESUMO

Adipose-derived mesenchymal stem cells (ADSCs) are a class of pluripotent stem cells isolated from the adipose tissue; they can differentiate into osteoblasts after induction and play an important role in bone repair. EGFL6 protein is secreted by adipocytes and osteoblasts and can promote endothelial cell migration and angiogenesis. This study aimed to explore the effect of recombinant EGFL6 protein on the osteogenic differentiation of ADSCs. The cells were incubated with fluorescein isothiocyanate-conjugated antibodies and analyzed by flow cytometry. Alizarin red staining and alkaline phosphatase staining were used to detect the osteogenic differentiation ability. mRNA expression was analyzed by real-time quantitative polymerase chain reaction (RT-qPCR). Protein expression was determined using Western blotting. The osteogenic differentiation ability of ADSCs isolated from the adipose tissue was significantly weakened after EGFL6 knockdown; this ability was restored upon the addition of EGFL6 recombinant protein. BMP2 knockdown inhibited the effect of EGFL6 recombinant protein on osteogenic differentiation. EGFL6 recombinant protein promoted osteogenic differentiation of ADSCs through the BMP2/SMAD4 signaling pathway. This may provide a potential target for the osteogenic differentiation of ADSCs.


Assuntos
Proteína Morfogenética Óssea 2/genética , Proteínas de Ligação ao Cálcio , Moléculas de Adesão Celular , Osteogênese/efeitos dos fármacos , Proteína Smad4/genética , Células-Tronco/efeitos dos fármacos , Fator de Crescimento Transformador beta/genética , Adipócitos/efeitos dos fármacos , Proteína Morfogenética Óssea 2/metabolismo , Proteínas de Ligação ao Cálcio/genética , Proteínas de Ligação ao Cálcio/metabolismo , Proteínas de Ligação ao Cálcio/farmacologia , Moléculas de Adesão Celular/genética , Moléculas de Adesão Celular/metabolismo , Moléculas de Adesão Celular/farmacologia , Diferenciação Celular/efeitos dos fármacos , Células Cultivadas , Humanos , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Proteínas Recombinantes/farmacologia , Transdução de Sinais/efeitos dos fármacos , Proteína Smad4/metabolismo , Fator de Crescimento Transformador beta/metabolismo
2.
Sci Rep ; 11(1): 21451, 2021 11 02.
Artigo em Inglês | MEDLINE | ID: mdl-34728727

RESUMO

In this study, a new percutaneous multi-function pedicle locator was designed for personalized three-dimensional positioning of a pedicle in minimally invasive spine surgery (MISS) without computer-assisted navigation technology. The proposed locator was used in a number of patients during MISS, and its advantages were analyzed. Based on the position of a pedicle determined by computed tomography (CT) and fluoroscopic images of a patient, 6 lines and 2 distances were used to determine the puncture point of a pedicle screw on skin, while 2 angles were used to indicate the direction of insertion of a pedicle guide needle from the patient's body surface. The results of the proposed locator were compared with those of the conventional freehand technique in MISS. The potential benefits of using the locator included enhanced surgical accuracy, reduced operation time, alleviation of the harmful intra-operative radiation exposure, lower costs, and shortened learning curve for young orthopedists.


Assuntos
Fluoroscopia/métodos , Procedimentos Cirúrgicos Minimamente Invasivos/métodos , Parafusos Pediculares/estatística & dados numéricos , Doenças da Coluna Vertebral/cirurgia , Cirurgia Assistida por Computador/métodos , Tomografia Computadorizada por Raios X/métodos , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Seguimentos , Humanos , Imageamento Tridimensional/métodos , Masculino , Pessoa de Meia-Idade , Prognóstico , Doenças da Coluna Vertebral/diagnóstico por imagem , Doenças da Coluna Vertebral/patologia , Punção Espinal
3.
Medicine (Baltimore) ; 99(31): e21390, 2020 Jul 31.
Artigo em Inglês | MEDLINE | ID: mdl-32756130

RESUMO

Prior evidence suggested that inflammation and inflammatory cytokines polymorphisms might be essential in the development of coronary heart disease (CHD) and cognitive decline. The following study investigated the associations between interleukin-35 (IL-35) polymorphisms and cognitive decline in CHD patients over a 2-year period.CHD patients were enrolled between January 2015 and January 2016. Cognitive function, including memory, orientation, verbal and attention were assessed using Telephone Interview for Cognitive Status-Modified (TICS-m) during a 2-year follow-up. Genotypes of the single nucleotide polymorphisms (SNPs), including rs2243115, rs568408, rs582054, rs583911, rs428253, rs4740 and rs393581 of IL-35 were examined by MassArray (Sequenom). The differences of TICS-m score between 2-year interval were used to estimate the cognitive decline; linear regression model was used to analyze the association between IL-35 polymorphisms and cognitive decline in CHD patients after a 2-year follow-up.The mean age of study individuals was 60.58 (±7.86) years old. There were 255 (68.5%) males and 117 (31.5%) female patients. The TICS-m scores, including overall cognition score, verbal attention and memory scores gradually decreased over a 2 year follow up period (P < .001, respectively), whereas there was no difference in orientation function score between the 1-year and 2-year follow-up (P = .448). Furthermore, after adjusting for age, sex, history of hypertension(HT) and Diabetes mellitus(DM), smoking, education, Therapy regimen (PCI, CABG, medication) left ventricular ejection fraction (LVEF), and the severity of coronary artery stenosis (Gensini score), no association was found between IL-35 rs2243115, rs568408, rs582054, rs583911, rs428253, rs4740 genotypes and cognitive decline in CHD patients over a 2-year period.Our data reveled that IL-35 polymorphisms was not associated with cognitive decline in CHD patients over a 2-year period. Yet, further studies are needed to confirm the role of cytokine gene polymorphisms in cognitive decline among CHD patients.


Assuntos
Disfunção Cognitiva/sangue , Doença das Coronárias/sangue , Interleucinas/sangue , Idoso , Disfunção Cognitiva/complicações , Doença das Coronárias/complicações , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Polimorfismo de Nucleotídeo Único , Estudos Retrospectivos
4.
BMC Psychiatry ; 18(1): 386, 2018 12 12.
Artigo em Inglês | MEDLINE | ID: mdl-30541503

RESUMO

BACKGROUND: Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental characterized by attention deficit, hyperactivity, emotional impulses and difficulty with cognitive functions. The Das-Naglieri Cognitive Assessment System (DN: CAS), as a theory-driven assessment kit, was explored based on Planning, Attention, Simultaneous, and Successive Theory (PASS). Recent researches have tried to explore the sensitivity and specificity of DN: CAS in diagnosing ADHD; nevertheless, these studies were performed in a small study population. The following study explores the cognitive functions in ADHD by the DN: CAS and to evaluate the DN: CAS's diagnostic value in ADHD. METHODS: A total of 135 children with ADHD and 140 healthy controls were enrolled to evaluate cognitive function by the DN: CAS. ROC curve and the area under the curve (AUC) were applied to evaluate the diagnostic value of DN: CAS on ADHD. RESULTS: Compared with healthy controls, children with ADHD had significantly lower scores in Planning, Simultaneous (Verbal-Spatial Relations), Attention in the four Subtests of DN: CAS, as well as the total scores. ROC analysis indicated that Planning and Attention of DN: CAS had good classification accuracy in diagnosing ADHD with AUCs of 0.808 and 0.730, respectively. CONCLUSIONS: The planning and attention assessment of DN: CAS revealed high sensitivity and specificity in diagnosing ADHD, thus suggesting that DN: CAS might be an effective tool in diagnosing ADHD.


Assuntos
Transtorno do Deficit de Atenção com Hiperatividade , Cognição , Testes de Estado Mental e Demência , Transtorno do Deficit de Atenção com Hiperatividade/diagnóstico , Transtorno do Deficit de Atenção com Hiperatividade/psicologia , Criança , Feminino , Humanos , Masculino , Testes Neuropsicológicos , Reprodutibilidade dos Testes
5.
Zhonghua Xin Xue Guan Bing Za Zhi ; 43(9): 788-92, 2015 Sep.
Artigo em Chinês | MEDLINE | ID: mdl-26652819

RESUMO

OBJECTIVE: To investigate this association between ABO blood groups and coronary heart disease (CHD) in the Chinese Guangxi Zhuang population. METHODS: From August 2010 to April 2013, we performed a case-control study in a Chinese Zhuang population, which included 1 024 CHD cases and 1 024 age and gender-matched non-CHD controls. The ABO blood groups and biological variables were measured by standard laboratory procedures. The Gensini score was used to evaluate the severity of coronary artery stenosis. RESULTS: Compared to non-CHD control group, CHD group had higher levels of fasting blood glucose ((6.71 ± 6.72) mmol/L vs. (4.98 ± 1.55) mmol/L, P < 0.001), LDL-C ((2.89 ± 1.18) mmol/L vs. (2.60 ± 1.05) mmol/L, P = 0.002) and CRP ((7.74 ± 7.32) mg/L vs. (2.93 ± 2.19)mg/L, P < 0.001) as well as higher proportion of history of hypertension (57.0% vs. 27.5%, P < 0.001), history of diabetes (29.6% vs. 9.6%, P < 0.001), family history of CHD (35.3% vs. 10.6%, P < 0.001) and smoking (51.0% vs. 38.2%, P < 0.001). Logistic analysis indicated that ABO blood groups were associated with CHD risk in the Chinese Zhuang population. Compared with group O, the group B individuals had a higher risk of CHD (OR = 2.33, 95% CI 1.88-2.90, P < 0.001), this result remained after adjustment for the conventional CHD risk factors (OR = 1.55, 95% CI 1.05-2.52, P = 0.047). In addition, there were significant differences of Gensini score between non-O subjects and group O subjects in the CHD group, and MACE at 1-year follow-up was similar between ABO blood groups of CHD individuals. CONCLUSION: ABO blood groups are associated with CHD risk in the Chinese Zhuang population.


Assuntos
Doença da Artéria Coronariana , Sistema ABO de Grupos Sanguíneos , Povo Asiático , Estudos de Casos e Controles , China , Estenose Coronária , Diabetes Mellitus , Humanos , Hipertensão , Fumar
6.
Neurosci Lett ; 511(1): 28-32, 2012 Mar 05.
Artigo em Inglês | MEDLINE | ID: mdl-22289688

RESUMO

IKK/NF-κB pathway is a principal player in the regulation of inflammation and apoptosis in spinal cord injury (SCI). We have previously shown that BMS-345541, a selective inhibitor of IKK, could inhibit NF-κB activation and ameliorate the motor function of hind limbs in rats after SCI. However its neuroprotective mechanism in SCI is still unclear. In this study, we investigated the neuroprotective effects of BMS-345541 and possible mechanisms by which BMS-345541 acts against inflammatory cells infiltration and apoptosis in rat SCI models. SCI induced neutrophils infiltration when examined by myeloperoxidase activity, which was prevented by BMS-345541 through inhibiting the expression of ICAM-1. BMS-345541 inhibited activation of caspase-3, and attenuated apoptotic cell death in spinal cord by modulating Bcl-2 and Bax expression following SCI. Our study indicates that BMS-345541 may play an important role on the anti-inflammatory and anti-apoptotic effects with experimental SCI. Our results imply the IKK inhibitors may be useful in the therapy of spinal cord injury.


Assuntos
Apoptose , Quinase I-kappa B/antagonistas & inibidores , Imidazóis/farmacologia , NF-kappa B/metabolismo , Infiltração de Neutrófilos/efeitos dos fármacos , Quinoxalinas/farmacologia , Traumatismos da Medula Espinal/tratamento farmacológico , Traumatismos da Medula Espinal/fisiopatologia , Animais , Anti-Inflamatórios não Esteroides/farmacologia , Caspase 3/metabolismo , Ativação Enzimática , Feminino , Quinase I-kappa B/metabolismo , Marcação In Situ das Extremidades Cortadas , Molécula 1 de Adesão Intercelular/metabolismo , Mielite/tratamento farmacológico , Mielite/metabolismo , Mielite/fisiopatologia , Fármacos Neuroprotetores/farmacologia , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Ratos , Ratos Sprague-Dawley , Transdução de Sinais/efeitos dos fármacos , Traumatismos da Medula Espinal/metabolismo , Traumatismos da Medula Espinal/patologia , Proteína X Associada a bcl-2
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...